US adult vaccination coverage for influenza, COVID-19, and RSV reported in observational data
How many eligible adults are getting their flu, COVID, and RSV shots?
An observational report describes vaccination coverage among eligible US adults for influenza, COVID-19, and RSV vaccines. Specific coverage…
A new report shows how many eligible adults across the United States received flu, COVID-19, and RSV vaccines before winter.
RSV disease severity compared to COVID-19 and influenza in hospitalized older adults
Study compares RSV severity to COVID-19 and flu in hospitalized older adults
An observational report from the IVY Network across 20 U.S. states examined disease severity among hospitalized adults aged ≥60 years with R…
A new report compares how serious respiratory syncytial virus is for hospitalized older adults against hospital stays for COVID-19 and the f…
Report examines vaccination coverage for influenza, RSV, and COVID-19 in US nursing home residents
Report examines vaccination rates for flu, RSV, and COVID-19 in U.S. nursing homes
A report describes vaccination coverage for influenza, respiratory syncytial virus, and COVID-19 among nursing home residents in the United …
A new report tracks flu, RSV, and COVID-19 vaccine coverage in U.S. nursing homes to see how many residents are getting these important prot…
RSV vaccine safety findings reported one year after recommendation for adults 60 and older
Early safety monitoring of RSV vaccines for older adults shows no major concerns
A post-recommendation safety assessment in the United States examined outcomes in persons aged 60 years and older who received an RSV vaccin…
Safety checks a year after RSV vaccines were recommended for adults 60 and older found no major concerns during this initial period.
ACIP recommends RSV vaccination for adults 60 years and older in the United States
Should adults over 60 get the RSV vaccine? New recommendations say yes.
The Advisory Committee on Immunization Practices (ACIP) issued a recommendation report for RSV vaccination in adults aged 60 years and older…
Adults 60 and older now have a clear official suggestion to get the RSV vaccine because the virus poses a significant health risk to this ag…
RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
How many infants are getting new RSV protection? A first look.
An observational report describes RSV immunization coverage among US infants born from October 2023 to March 2024 who received nirsevimab mo…
For the first time, doctors have tools to protect youngest babies from RSV with new shots or pregnancy vaccines.
CDC recommends clesrovimab for preventing severe RSV lower respiratory infections in infants
CDC recommends new antibody to protect infants from severe RSV
The CDC has issued a recommendation for the use of clesrovimab to prevent severe respiratory syncytial virus-associated lower respiratory tr…
The CDC now recommends a new antibody to help protect infants from severe respiratory syncytial virus infections.